Phase II randomized trial of surgery followed by chemoradiation plus cetuximab for high-risk squamous cell carcinoma of the head and neck (RTOG 0234) - Harari,P.M.; Harris,J.; Kies,M.S. (Int J Radiat Oncol Biol Phys, 2007)